|
Spruce Biosciences Inc (NASDAQ: SPRB) |
|
Spruce Biosciences Inc
SPRB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Spruce Biosciences Inc 's sales fell
by -75.86 % in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Spruce Biosciences Inc net loss increased from $-10 millions, to $-24 millions in IV. Quarter 2024,
• More on SPRB's Growth
|
|
Spruce Biosciences Inc realized a net loss in trailing twelve months.
Spruce Biosciences Inc realized cash reduction of $ -1.4 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on SPRB's Valuation
|
|
|
|
|
Spruce Biosciences Inc realized net loss in trailing twelve months.
Spruce Biosciences Inc realized cash outflow of $ -1.4per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
Spruce Biosciences Inc Price to Book Ratio is at 0.19 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01
• More on SPRB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com